These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17188766

  • 1. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.
    Baravelli M, Fantoni C, Rogiani S, Farina S, Anzà C, Caltabiano V, Forzani T, Salerno-Uriarte JA.
    Int J Cardiol; 2007 Sep 14; 121(1):23-9. PubMed ID: 17188766
    [Abstract] [Full Text] [Related]

  • 2. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M, Salerno-Uriarte D, Guzzetti D, Rossi MC, Zoli L, Forzani T, Salerno-Uriarte JA.
    Int J Cardiol; 2005 Oct 20; 105(1):53-7. PubMed ID: 16207545
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
    Yang P, Guo T, Tang YM, Zhao L, Li SM, Liu ZM.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun 20; 36(6):517-22. PubMed ID: 19100065
    [Abstract] [Full Text] [Related]

  • 4. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Chan PS.
    J Am Coll Cardiol; 2006 May 02; 47(9):1820-7. PubMed ID: 16682307
    [Abstract] [Full Text] [Related]

  • 5. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, Bigger JT.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1399-404. PubMed ID: 17010802
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258
    [Abstract] [Full Text] [Related]

  • 7. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B, Kowalczyk J, Lenarczyk R, Kowalski O, Sędkowska A, Cebula S, Musialik-Łydka A, Kalarus Z.
    Kardiol Pol; 2012 Nov 06; 70(5):447-55. PubMed ID: 22623232
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, Kasamaki Y, Yoshida A, Kato T.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2268-74. PubMed ID: 17161258
    [Abstract] [Full Text] [Related]

  • 9. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T, Credner S, Li YG, Bender B, Hohnloser SH.
    Z Kardiol; 2000 Dec 05; 89 Suppl 3():57-61. PubMed ID: 10810786
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.
    Am J Cardiol; 2007 Aug 15; 100(4):598-604. PubMed ID: 17697813
    [Abstract] [Full Text] [Related]

  • 11. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG, MASTER Trial Investigators.
    J Am Coll Cardiol; 2008 Nov 11; 52(20):1607-15. PubMed ID: 18992649
    [Abstract] [Full Text] [Related]

  • 12. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis.
    Gehi AK, Stein RH, Metz LD, Gomes JA.
    J Am Coll Cardiol; 2005 Jul 05; 46(1):75-82. PubMed ID: 15992639
    [Abstract] [Full Text] [Related]

  • 13. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, Dettmer MM, Rosenbaum DS, ABCD Trial Investigators.
    J Am Coll Cardiol; 2009 Feb 10; 53(6):471-9. PubMed ID: 19195603
    [Abstract] [Full Text] [Related]

  • 14. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R, Michałkiewicz D, Cholewa M, Jacewicz K, Gniłka A, Adamus J.
    Pol Merkur Lekarski; 2006 Oct 10; 21(124):310-3. PubMed ID: 17205766
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive risk stratification for sudden cardiac death by heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction.
    Sulimov V, Okisheva E, Tsaregorodtsev D.
    Europace; 2012 Dec 10; 14(12):1786-92. PubMed ID: 22849973
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal.
    Chan PS, Bartone C, Booth T, Kereiakes D, Chow T.
    Am Heart J; 2007 Apr 10; 153(4):523-9. PubMed ID: 17383288
    [Abstract] [Full Text] [Related]

  • 17. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung E, Menon S, Nallamothu BK, Chan PS.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):50-8. PubMed ID: 17207722
    [Abstract] [Full Text] [Related]

  • 18. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, Voss F, Hilbel T, Niroomand F, Katus HA, Schoels W.
    Basic Res Cardiol; 2003 Jul 02; 98(4):259-66. PubMed ID: 12835955
    [Abstract] [Full Text] [Related]

  • 19. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):456-63. PubMed ID: 16412877
    [Abstract] [Full Text] [Related]

  • 20. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M, Forleo C, Guida P, Romito R, Sorgente A, Sorrentino S, Catucci S, Mastropasqua F, Pitzalis M.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):225-31. PubMed ID: 17631214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.